Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

ABSTRACT: Polycystic ovary syndrome (PCOS) is now recognized as an important metabolic as well as reproductive disorder conferring substantially increased risk for type 2 diabetes. Affected women have marked insulin resistance, independent of obesity. This article summarizes the state of the science since we last reviewed the field in the Endocrine Reviews in 1997. There is general agreement that obese women with PCOS are insulin resistant, but some groups of lean affected women may have normal insulin sensitivity. There is a post-binding defect in receptor signaling likely due to increased receptor and insulin receptor substrate-1 serine phosphorylation that selectively affects metabolic but not mitogenic pathways in classic insulin target tissues and in the ovary. Constitutive activation of serine

SUBMITTER: Diamanti-Kandarakis E 

PROVIDER: S-EPMC5393155 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature